San Diego, CA -- (SBWire) -- 06/15/2017 --An investigation on behalf of investors of Endo International plc – (NASDAQ:ENDP) shares over potential securities laws violations by Endo International in connection with certain financial statements was announced.
Investors who purchased shares of Endo International plc – (NASDAQ:ENDP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call 858-779-1554.
The investigation by a law firm focuses on whether a series of statements by Endo International regarding its business, its prospects and its operations were materially false and misleading at the time they were made.
Shares of Endo International plc – (NASDAQ:ENDP) reached as high as $94.46 per share in April 2015.
On June 8, 2017, the U.S. Food and Drug Administration (the "FDA") instructed Endo International plc to pull its powerful opioid painkiller Opana ER off the U.S. market. According to the FDA, Opana's "high risk of abuse and potential to help spread HIV and hepatitis C" necessitated its removal from the market.
Shares of Endo International plc – (NASDAQ:ENDP) closed on June 9, 2017 at $11.49 per share.
Those who purchased shares of Endo International plc – have certain options and should contact the Shareholders Foundation.
Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com
Endo International Plc – (NASDAQ:ENDP) Investor Investigation over Possible Violations of Securities Laws
An investigation for investors in Endo International plc – (NASDAQ:ENDP) shares over potential securities laws violations by Endo International plc was announced and NASDAQ:ENDP stockholders should contact the Shareholders Foundation.